about
Antimicrobial peptides in the first line defence of human colon mucosaNeutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophagesThe antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infectionPhenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategyLactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasisAntibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A.Proteome analysis of vernix caseosa.Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37.Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides.Impaired release of antimicrobial peptides into nasal fluid of hyper-IgE and CVID patients.Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns.Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosisImproved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.Boosting innate immunity: development and validation of a cell-based screening assay to identify LL-37 inducers.Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.First line of defense in early human life.Assays for Identifying Inducers of the Antimicrobial Peptide LL-37.Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention studyCiprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon EpitheliaCathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humansThe role of the multifunctional peptide LL-37 in host defense.Battle and balance at mucosal surfaces--the story of Shigella and antimicrobial peptides.Involvement of the antimicrobial peptide LL-37 in human atherosclerosis.Antimicrobial peptides important in innate immunity.Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections.A review of the innate immune defence of the human foetus and newborn, with the emphasis on antimicrobial peptides.Cathelicidins positively regulate pancreatic β-cell functions.Glucocorticoid dexamethasone down-regulates basal and vitamin D3 induced cathelicidin expression in human monocytes and bronchial epithelial cell line.Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophagesPhenylbutyrate induces cathelicidin expression via the vitamin D receptor: Linkage to inflammatory and growth factor cytokines pathways.Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis.Differential host immune responses to epidemic and endemic strains of Shigella dysenteriae type I.Phenylbutyrate induces antimicrobial peptide expression.PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells.Neutrophil-derived cathelicidin protects from neointimal hyperplasia.Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia.Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37.Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparationInduction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection
P50
Q24308002-C09EA93C-2336-464E-9391-7CF0BB71955DQ24652851-D4A54B9E-F3BD-4869-A564-EEC92A963412Q28244066-FBFF87ED-DE51-4D49-BA7C-C2B809D4E51AQ28478430-4BBEF358-EA60-4BFD-9844-1A6E3A158F78Q28484943-A30B19BC-6E22-4308-9780-B5530E3C9F1FQ31039333-92381196-1FDA-43B8-9546-10F541A9719AQ33255744-C4C40E15-DAAB-49C3-9A46-066EBB050D46Q33641535-B5552936-2FDE-48D2-B968-DEB98F67AC47Q33685291-E4E6C657-A2C5-4450-88FF-3CFCD33EAB66Q34117479-48E9C7C1-F67B-4D96-AE5A-DF630940FCD6Q34144175-AFD9F725-11DA-4888-A5B2-2E0B06519064Q34265202-F1903D21-4019-4E61-83BB-3DBCD91F3A3EQ34670730-9ED174F1-CD6F-4761-9732-4ED299186DC6Q34694936-B50D3E51-1EFA-4CE6-862A-52E3FF6A4B25Q34864069-93E64CE0-E967-4271-BB8F-2A3E50F656E6Q35783492-0F83BD39-0B41-4036-8B8F-F611DD07FF3AQ35964373-4BC635BC-82D8-47A9-90A2-3E1AD0803909Q36232935-32B0DC02-FC60-450C-9A41-6278045D64A7Q36496314-01CA2A7C-CD86-4AF0-9B02-FD5E8C94F211Q36683648-4B08036A-4317-4ACC-9D6A-0B9A86446C6AQ36804326-3C1A4C9E-277E-464F-82D6-C2DF99E35474Q37175175-75261D43-4E5D-49BC-AC3D-38ED9C9DE5C1Q37759806-710A63F8-F262-410C-9D69-3B31D2FD08C2Q37862395-B9FD7BE4-CE08-4F22-8631-E366E5790654Q37919159-2FF29AF4-18B8-442E-B9EF-2B7753EC4B53Q38018928-7C0AD041-E386-44ED-B91E-F94E847BC43DQ38214913-EC5977E9-554D-4E95-90DE-E2D47E0766E2Q38822717-3CFF97B3-5D94-4AC3-B994-62D646C6C4F8Q38836259-3713A2F1-C3C6-4772-AA85-B4D5C9586663Q38848578-9814CCA4-1BA6-41FB-8152-4B517ED347C5Q38933832-383C0182-628C-4066-A1E7-E9E2713F7A25Q38973069-FECE17D6-0C0B-4674-A8ED-DED1FC42B433Q39408427-52250EF5-FBB2-4691-B140-FB40B4B5A4EFQ39796789-93FEC941-169C-414F-86EA-FFC813EEBC86Q39956942-6EF0D808-7FAF-4B8B-8ED6-4BD5D8C4F78EQ40000791-2452D03A-0ADA-488C-998A-9BFB1E5C2C20Q40239307-585F62AC-C74D-4F7B-A81C-724AC8BB7E52Q40410408-03F690AE-4C57-41DC-A177-8EDAC3CF8A9FQ40882637-01F1DD3B-36B0-444E-A92F-3CAF00F433CBQ41058869-1086D1E3-3FB8-4ED1-83F3-8132D74A4D7B
P50
description
professor at Karolinska Institutet
@en
professor på Karolinska Institutet
@sv
name
Birgitta Agerberth
@ast
Birgitta Agerberth
@en
Birgitta Agerberth
@es
Birgitta Agerberth
@fr
Birgitta Agerberth
@nl
Birgitta Agerberth
@sv
type
label
Birgitta Agerberth
@ast
Birgitta Agerberth
@en
Birgitta Agerberth
@es
Birgitta Agerberth
@fr
Birgitta Agerberth
@nl
Birgitta Agerberth
@sv
prefLabel
Birgitta Agerberth
@ast
Birgitta Agerberth
@en
Birgitta Agerberth
@es
Birgitta Agerberth
@fr
Birgitta Agerberth
@nl
Birgitta Agerberth
@sv
P21
P31
P6634
birgitta-agerberth-a5a6434a